What’s your next step with polycythemia vera?

Medical expert Q&A featuring: Dr. Jennifer Vaughn | Associate Professor of Hematology
The Ohio State University Comprehensive Cancer Center – The James | Webinar on Oct. 14, 2026

Join hematologist Dr. Jennifer Vaughn of The Ohio State University Comprehensive Cancer Center – The James and longtime PV patient advocate Nick Napolitano for a direct conversation about living with polycythemia vera (PV).

REGISTER and get a free download toolkit with a program summary and resource links after the program.

In this free program, Dr. Jennifer Vaughn Associate Professor of Hematology at The Ohio State University Comprehensive Cancer Center – The James, walks through how doctors determine your risk category, what to track between appointments, and the full range of PV treatment options available today.

Hear from Nick Napolitano, PV patient advocate coming up on 10 years since his diagnosis back in 2016. He shares his personal experience

Grab your own downloadable
PV Toolkit after the program.

Program Topics

  • Understand your risk category: Learn how doctors decide whether you’re low-risk or high-risk for a blood clot (thrombosis).
  • “Is PV really a cancer?”: Dr. Vaughn explains what’s happening in your bone marrow in plain terms, and what that word does and doesn’t mean for your outlook.
  • Track what matters between visits: Walk away with a clear list of the labs and symptoms worth watching, from hematocrit and ferritin to fatigue and itching.
  • Speak up for the care you need: Get practical language for bringing symptoms, cost concerns, and quality-of-life questions to your doctor, even during a short appointment.
  • See the full range of PV treatments today: From phlebotomy and aspirin, to hydroxyurea, interferon therapy, and the newest FDA-approved option.
Nick Napolitano and Dr. Jennifer Vaughn discuss polycythemia vera treatment options

Program Partners

MPN Research Foundation

From groundbreaking studies to insightful patient stories, MPN Research Foundation is at the forefront of making real change for those directly affected by essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Founded by a PV patient, MPNRF directly connects patients, researchers, and clinicians while offering educational resources like the You and MPN series to help navigate care options.

Blood Cancer United

Thank you to Blood Cancer United for their partnership. They are here for you with information about clinical trials, resources, and dedicated support through their Information Specialists.


Program Sponsor

Thank you to our sponsor for its support of our independent patient education program. The Patient Story retains full editorial control over all content.


This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.